Signify N.V. (ENXTAM:LIGHT) entered into an agreement to acquire Fluence Bioengineering, Inc. from OSRAM Licht AG (HMSE:OSR) for approximately $270 million on December 20, 2021. Fluence team will be joining Signify N.V. The acquisition is expected to close in the first half of 2022, subject to regulatory approvals and other conditions. In the trailing 12 months (October 2020 to September 2021),Fluence generated USD 141 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51 EUR | 0.00% | -0.39% | 0.00% |
Mar. 19 | OSRAM Licht AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | OSRAM Licht AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 5.13B | |
-5.80% | 1.22B | |
+3.14% | 1.08B | |
-16.69% | 1.03B | |
-16.94% | 1.03B | |
+5.91% | 896M | |
-6.12% | 583M | |
-32.85% | 588M | |
-18.02% | 468M | |
-23.61% | 390M |
- Stock Market
- Equities
- OSR Stock
- News OSRAM Licht AG
- Signify N.V. entered into an agreement to acquire Fluence Bioengineering, Inc. from OSRAM Licht AG on December 20, 2021.